Syntagon

George Köllner joins Syntagon Quality Assurance and regulatory team

Tue, Jan 31, 2012 15:35 CET

Leading contract research provider, Syntagon, is delighted to announce that it has entered into a collaborative agreement with world-class Quality Assurance (QA) expert George Köllner.George brings with him more than 20 years’ experience from the pharma industry. He has served as Director of Quality Assurance at AstraZeneca where he led the development and implementation of modern Quality Assurance systems in API Process Development. “I am very excited having George on our team, it will allow us to better serve our customers by strategically setting the quality levels best suited for the

Syntagon introduces strategic pricing initiative

Thu, Apr 22, 2010 10:00 CET

Leading contract research organisation, Syntagon, has unveiled a strategic pricing initiative that will see substantial cost savings for biotechnology and pharmaceutical customers taking compounds into phase I and phase II clinical trials.“Now, more than ever, customers are under growing pressure to make their limited resources stretch further. Cost-efficiency is increasingly critical; and maintaining cash is of utmost importance, especially for smaller companies,” says John Cameron, Director of Sales and Marketing at Syntagon. The initiative has been made possible by Syntagon’s decade-long

Share

George Köllner joins Syntagon Quality Assurance and regulatory team

Syntagon introduces strategic pricing initiative

Media